KRRO

KORRO BIO INC

KRRO·500946108·US·Common Stock·Healthcare - Biotechnology-Activist

KRRO (KORRO BIO INC) is held by 66 institutional investors as of Q2 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($12.5M), BlackRock, Inc. ($10.8M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($7.1M). Net institutional sentiment: Bullish.

66
Holders
(5 Elite)
$78.6M
Total Value
77% (65)
Consensus
50 buying - 15 selling
13F: Insider & Congress: Updated regularly
KRRO

Smart Money Verdict

View all
Loading verdict
Held by 66 funds
5 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 28, 2026 · Activists Aug 14, 2026 · Congress none

InsiderFFFORMELA JEAN FRANCOISSell $711.96Aug 26, 2026
InsiderFFFORMELA JEAN FRANCOISSell $3KAug 26, 2026
InsiderFFFORMELA JEAN FRANCOISSell $68KAug 19, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
951,783(-8.5%)$12.5M0.0%+27.26%
0
Increased
817,621(+77.7%)$10.8M0.0%-47.57%
42
Increased
540,968(+136.8%)$7.1M0.0%+12.56%
44
Increased
454,778(+46.3%)$6M0.0%+18.76%
37
Unchanged
450,045$5.9M0.0%+27.26%
0
Increased
298,974(+11.7%)$3.9M0.0%-10.94%
30
Increased
296,870(+71.0%)$3.9M0.0%-47.78%
40
Increased
232,587(+65.7%)$3.1M0.0%-48.85%
39
Increased
223,551(+50.5%)$2.9M0.0%+18.29%
37
Increased
178,071(+7.6%)$2.3M0.0%-14.18%
28
Increased
124,726(+82.1%)$1.6M0.0%+8.80%
40
Increased
118,434(+86.2%)$1.6M0.0%-41.98%
40
Increased
116,983(+131.5%)$1.5M0.0%-11.46%
41
Decreased
110,524(-18.9%)$1.5M0.0%+31.44%
0
Increased
105,453(+386.5%)$1.4M0.0%-25.63%
41
Increased
88,089(+52.7%)$1.2M0.0%-51.33%
35
Increased
74,901(+80.3%)$987,1950.0%+15.62%
38
New
54,289$715,5290.0%+3.79%
34
Increased
52,720(+46.5%)$694,8500.0%-2.95%
34
New
51,707$681,4980.0%+3.79%
38

Showing 1-20 of 71

1 / 4
KRROKRROKORRO BIO INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used